|
|
|
|
|
|
| Wockhardt, Sun get US okay for generic drug | 19-NOV-09 |
|
| Indian drug companies Wockhardt and Sun Pharmaceutical Industries have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug. |
|
|
|
| Model N to invest Rs 37cr | 19-NOV-09 |
|
| The company has, so far, invested $3.8 million (about Rs 17.48 crore) in India, said Zack Rinat, founder and chief operating officer. Globally, the company will invest $120 million (Rs 555 crore) during this financial year. |
|
|
|
| India Inc discovers the power of two | 18-NOV-09 |
|
| When US-based drug major Merck bought Schering-Plough early this month, it decided to go off the beaten track. Instead of having one managing director (MD) for the merged entity, it decided to retain both: Naveen A Rao will continue to head Merck’s subsidiary MSD Pharmaceuticals in India and K G Ananthakrishnan will retain his position as MD of Schering-Plough’s subsidiary Fulford India. |
|
|
|
|
|
|
| Glenmark settles patent dispute with Medicis | 16-NOV-09 |
|
| Pharma firm Glenmark today said it has settled all pending patent disputes with US-based Medicis Pharmaceutical Corp over a skin disease drug, besides signing a licensing agreement for new drug delivery system (NDDS). |
|
|
|
|
|
|
| Novo Nordisk eyes India as insulin hub for sub-continent | 16-NOV-09 |
|
| Denmark-based world leader in diabetes care Novo Nordisk can look at making India the hub for manufacturing insulin for the sub-continent. The company today inaugurated a dedicated facility with a capacity of 26 million vials per annum in partnership with Ahmedabad based Torrent Pharmaceuticals Ltd. Torrent has been manufacturing insulin for Novo Nordisk since the early nineties. |
|
|
|
| Reametrix scouts for strategic partners | 16-NOV-09 |
|
| Reametrix, a Bangalore-based company that provides basic research and assay development services to biotechnology and pharmaceutical companies, is scouting for strategic partners to take TriTstat, a critical diagnostic product for managing HIV patients, to the global markets. |
|
|
|
| Novo Nordisk looks to make India hub for South Asia | 15-NOV-09 |
|
| May manufacture insulin in the country for the sub-continent. Denmark-based Novo Nordisk, a world leader in diabetes care, is looking at India as a hub for manufacturing insulin for the entire sub-continent. The company today inaugurated a dedicated facility with a capacity of 26 million vials per annum in partnership with Ahmedabad-based Torrent Pharmaceuticals Ltd. |
|
|
|
| Glenmark Generics gets US FDA nod for Ciclopirox Olamine | 14-NOV-09 |
|
| Glenmark Generics today said it has received ANDA (abbreviated new drug application) approval from the United States Food and Drug Administration for Ciclopirox Olamine cream, used in the treatment of dermatological infections. |
|
|
|
| Deccan Cargo's global ops put on hold for now | 11-NOV-09 |
|
| G R Gopinath, who kickstarted his Deccan Cargo air services during May earlier this year, has put the international operations of the cargo ariline on hold even as the domestic operations kickstarted this week. |
|
|
|
| Accenture to hire 8,000 in India by end of 2010 | 10-NOV-09 |
|
| “We are 42,000 right now and we imagine we will be about 50,000 by the end of 2010,” Accenture Chairman and Chief Executive Officer William D Green said on the sidelines of the India Economic Summit. |
|
|
|
| Biocon hums with plans, pitches for global top 3 slot | 07-NOV-09 |
|
| Biocon was scouting for more strategic alliances and exploring opportunities for outlicensing its biotech drugs under development, as it pitches for a slot among the top three bio-pharmaceutical players across the globe, said Kiran Mazumdar-Shaw, chairman and managing director. |
|
|
|
Content Guide
